Last reviewed · How we verify

NCT06948903

Relationship Between Central Sensitization Symptoms and Cognitive Dysfunction in Fibromyalgia

Recruiting now Last updated 12 September 2025
What this trial tests

trial testing Central Sensitization Inventory in Fibromyalgia in 100 participants. Currently enrolling.

Timeline
10 January 2023
Primary endpoint
1 August 2025
1 October 2025

Quick facts

Lead sponsorSultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment100
Start date10 January 2023
Primary completion1 August 2025
Estimated completion1 October 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

Who can join

Adults 18 to 65, any sex, with Fibromyalgia or Cognitive Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to investigate the relationship between central sensitization parameters and cognitive dysfunction in patients with fibromyalgia.The main questions it aims to answer are: Do central sensitization symptoms affect cognitive dysfunction in patients with fibromyalgia? To what extent do central sensitization symptoms affect objective and subjective cognitive complaints in fibromyalgia patients? How do cognitive complaints relate to other clinical parameters, including disease severity, in these patients?

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Central Sensitization Inventory

Trials testing the same drug.

Other recruiting trials for Fibromyalgia

Currently open trials in the same condition.

Other Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06948903.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing